Healthequity Stock Earnings Per Share
| HQY Stock | USD 79.85 0.02 0.03% |
HealthEquity fundamentals help investors to digest information that contributes to HealthEquity's financial success or failures. It also enables traders to predict the movement of HealthEquity Stock. The fundamental analysis module provides a way to measure HealthEquity's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to HealthEquity stock.
HealthEquity | Earnings Per Share |
HealthEquity Company Earnings Per Share Analysis
HealthEquity's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current HealthEquity Earnings Per Share | 0.64 X |
Most of HealthEquity's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, HealthEquity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
HealthEquity Earnings Per Share Driver Correlations
Understanding the fundamental principles of building solid financial models for HealthEquity is extremely important. It helps to project a fair market value of HealthEquity Stock properly, considering its historical fundamentals such as Earnings Per Share. Since HealthEquity's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of HealthEquity's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of HealthEquity's interrelated accounts and indicators.
Click cells to compare fundamentals
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
HealthEquity Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
According to the company disclosure, HealthEquity has an Earnings Per Share of 0.64 times. This is 92.35% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The earnings per share for all United States stocks is 79.49% higher than that of the company.
HealthEquity Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses HealthEquity's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of HealthEquity could also be used in its relative valuation, which is a method of valuing HealthEquity by comparing valuation metrics of similar companies.HealthEquity is currently under evaluation in earnings per share category among related companies.
HealthEquity Fundamentals
| Return On Equity | 0.0284 | ||||
| Return On Asset | 0.0256 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 7.45 B | ||||
| Shares Outstanding | 86.16 M | ||||
| Shares Owned By Insiders | 2.22 % | ||||
| Shares Owned By Institutions | 97.78 % | ||||
| Number Of Shares Shorted | 2.98 M | ||||
| Price To Earning | 525.29 X | ||||
| Price To Book | 3.38 X | ||||
| Price To Sales | 6.88 X | ||||
| Revenue | 999.59 M | ||||
| Gross Profit | 490.09 M | ||||
| EBITDA | 281.21 M | ||||
| Net Income | 55.71 M | ||||
| Cash And Equivalents | 176.89 M | ||||
| Cash Per Share | 2.09 X | ||||
| Total Debt | 933.14 M | ||||
| Debt To Equity | 0.54 % | ||||
| Current Ratio | 2.46 X | ||||
| Book Value Per Share | 23.63 X | ||||
| Cash Flow From Operations | 242.83 M | ||||
| Short Ratio | 5.20 X | ||||
| Earnings Per Share | 0.64 X | ||||
| Price To Earnings To Growth | 2.29 X | ||||
| Target Price | 99.23 | ||||
| Number Of Employees | 3.13 K | ||||
| Beta | 0.55 | ||||
| Market Capitalization | 6.92 B | ||||
| Total Asset | 3.24 B | ||||
| Retained Earnings | 205.63 M | ||||
| Working Capital | 440.35 M | ||||
| Current Asset | 143.05 M | ||||
| Current Liabilities | 12.11 M | ||||
| Net Asset | 3.24 B |
About HealthEquity Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze HealthEquity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HealthEquity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HealthEquity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out HealthEquity Piotroski F Score and HealthEquity Altman Z Score analysis. For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for HealthEquity Stock analysis
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance |
Is HealthEquity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HealthEquity. If investors know HealthEquity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HealthEquity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share 0.64 | Revenue Per Share 11.682 | Quarterly Revenue Growth 0.122 | Return On Assets 0.0256 |
The market value of HealthEquity is measured differently than its book value, which is the value of HealthEquity that is recorded on the company's balance sheet. Investors also form their own opinion of HealthEquity's value that differs from its market value or its book value, called intrinsic value, which is HealthEquity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HealthEquity's market value can be influenced by many factors that don't directly affect HealthEquity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HealthEquity's value and its price as these two are different measures arrived at by different means. Investors typically determine if HealthEquity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HealthEquity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.